CoChat

Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib

Open access

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Estimation of low-density lipoprotein cholesterol (LDL-C) using the Friedewald (FR) formula is often inaccurate when triglycerides are elevated or VLDL particle composition is altered. We hypothesized that LDL-C estimation by the FR formula and other measurement methods might also be inaccurate in individuals treated with a cholesteryl ester transfer protein (CETP) inhibitor. An assay comparison study was conducted using pre and posttreatment serum samples from 280 of the 811 patients treated with the CETP inhibitor anacetrapib in the DEFINE study (determining the efficacy and tolerability of CETP inhibition with anacetrapib). After 24 weeks of treatment with anacetrapib, mean LDL-C values by FR formula, Roche direct method (RDM) and Genzyme direct method (GDM) deviated from that measured by the β-quantification (BQ) reference method by -12.2 ± 7.5, -10.2 ± 6.6, -10.8 ± 8.8 mg/dl, respectively. After treatment with anacetrapib, the FR formula and detergent-based direct methods provided lower LDL-C values than those obtained by the BQ reference method. The bias by the FR formula appeared to be due to an overestimation of VLDL-C by the TG/5 component of the formula. Evaluation of the clinical significance of these findings awaits comprehensive lipid and cardiovascular outcome data from ongoing Phase III clinical studies of anacetrapib.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1194/jlr.m032615

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Analysis of correlations and corresponding individual differences between LDL-C values measured by the Friedewald formula and the 𝛃 -quantifi cation method at baseline (A, C) and at week 24 (B, D). In (C) and (D), the mean of these differences (bias) is shown as the long dashed line and the upper and lower boundaries are displayed as short dashed lines (±1.96 × SD).
Fig. 1 Analysis of correlations and corresponding individual differences between LDL-C values measured by the Friedewald formula and the 𝛃 -quantifi cation method at baseline (A, C) and at week 24 (B, D). In (C) and (D), the mean of these differences (bias) is shown as the long dashed line and the upper and lower boundaries are displayed as short dashed lines (±1.96 × SD).CC-BY · From the PDF
Fig. 2 Correlation between VLDL-C estimated by total plasma triglyceride and VLDL-C directly measured by ultracentrifugation at baseline (A) and at week 24 (B).
Fig. 2 Correlation between VLDL-C estimated by total plasma triglyceride and VLDL-C directly measured by ultracentrifugation at baseline (A) and at week 24 (B).CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 56

Metadata

Authors
Davidson, M., Liu, S. X., Barter, P., Brinton, E. A., Cannon, C. P., Gotto, A. M., Leary, E. T., Shah, S., Stepanavage, M., Mitchel, Y., & Dansky, H. M.
Affiliations
  • University of Chicago (US)
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
  • The Heart Research Institute (AU)
  • Foundation for Biomedical Research (US)
  • Brigham and Women's Hospital (US)
  • Weill Cornell Medicine (US)
  • Pacific Biomarkers (United States) (US)
Corresponding author
Davidson, Michael
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2013-02
Volume
54
Issue
2
Pages
467-472
ISSN
0022-2275 (ISSN-L)
OpenAlex
W2108169863
Cited by
56
References
19
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 12 · 2016: 5 · 2015: 5 · 2014: 6 · 2013: 10
FWCI
6.84
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Lipid Research (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
Keywords
LDL cholesterol estimation, anacetrapib, cholesteryl ester transfer protein inhibitors, Friedewald formula, VLDL cholesterol, triglyceride elevation, assay bias
MeSH terms
Aged, Blood Chemical Analysis, Clinical Trials as Topic, Female, Humans, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Chemical Precipitation, Reference Standards, Time Factors, Ultracentrifugation, Dextran Sulfate, Oxazolidinones, Cholesterol Ester Transfer Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.